Lutetium-177 (Lu-177) PSMA therapy is a targeted cancer treatment. It’s offered at Anadolu Medical Center in Istanbul, Turkey. The complete treatment cycle costs $8700 USD. Anadolu Medical Center is JCI accredited and affiliated with Johns Hopkins Medicine, ensuring high standards of care.
This therapy targets prostate cancer that has spread. It uses a radioactive drug, Lutetium-177, linked to PSMA. PSMA is a protein found on most prostate cancer cells. The drug delivers radiation directly to the cancer cells. This minimizes damage to healthy tissues.
How the Treatment Works
The treatment is given through an intravenous (IV) line. You will typically stay in the hospital for 3-4 nights per cycle. Doctors space cycles 6-8 weeks apart. Before starting, you’ll need a recent PSMA PET-CT scan. This helps doctors plan your treatment.
What’s Included in the Package?
- Lu-177 medication
- Treatment-related materials
- Nuclear Medicine Examination
- Consultation with Dr. Kezban Berberoglu
- Blood tests (if needed)
- Mag-3 Kidney Scintigraphy (if needed)
The package does not cover complications, longer hospital stays, or extra medications.
Meet the Specialist
Assoc. Prof. Dr. Kezban Berberoglu is a Nuclear Medicine Specialist. She is an expert in Lu-177 PSMA therapy. She focuses on evaluating patients and monitoring results after treatment. She has unique training and experience in this field.
About Anadolu Medical Center
Anadolu Medical Center is the first hospital in Turkey to earn JCI accreditation. This shows their commitment to quality and patient safety. Their affiliation with Johns Hopkins Medicine provides access to the latest medical advancements.
Payment requires an advance deposit. This covers the drug procurement costs, ranging from $4,500 to $6,000 and is non-refundable.
If you are interested in learning more about Lu-177 PSMA therapy at Anadolu Medical Center, please contact us to discuss your individual case.